Bioconjugate Chemistry

Journal

Publication Venue For

  • Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI.  28:1031-1040. 2017
  • EDB fibronectin specific peptide for prostate cancer targeting.  26:830-838. 2015
  • Preparation and preliminary evaluation of a biotin-targeted, lectin-targeted dendrimer-based probe for dual-modality magnetic resonance and fluorescence imaging.  18:1474-1482. 2007
  • Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.  15:1264-1274. 2004
  • Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.  14:302-310. 2003
  • Evaluation of different α-galactosyl glycoconjugates for use in xenotransplantation.  13:571-581. 2002
  • De novo synthesis of a new diethylenetriaminepentaacetic acid (DTPA) bifunctional chelating agent.  13:317-326. 2002
  • Synthesis of the first diethylenetriaminepentahydroxamic acid (DTPH) bifunctional chelating agent.  13:327-332. 2002
  • Further studies on the protein conjugation of hydroxamic acid bifunctional chelating agents: Group-specific conjugation at two different loci.  10:18-23. 1999
  • Conjugation of unprotected trisuccin, N-[tris[2-[(N-hydroxyamino)carbonyl]ethyl]methyl]succinamic acid, to monoclonal antibody CC49 by an improved active ester protocol.  8:766-771. 1997
  • Synthesis of N-[Tris[2-[[N-(benzyloxy)amino]carbonyl]ethyl]methyl]succinamic Acid, Trisuccin. Hydroxamic Acid Derivatives as a New Class of Bifunctional Chelating Agents.  4:194-198. 1993
  • International Standard Serial Number (issn)

  • 1043-1802
  • Electronic International Standard Serial Number (eissn)

  • 1520-4812